Apoptosis inducer 67
Apoptosis inducer 67 is an Apoptosis inducer. Apoptosis inducer 67 inhibits PDGFR-β, SRC, c-MET, and ERK signaling and activates p53/Caspase-3. Apoptosis inducer 67 can be used for research on pancreatic cancer.
For research use only. We do not sell to patients.
- CAS No.: 3031972-22-9
- Formula: C24H17FN2O
- Molecular Weight:368.40
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
All Caspase Isoforms
More
Biological Activity
Description
IC50 & Target
[1]|
Caspase-3 |
PDGFR-β |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| MIA PaCa-2 | IC50 |
0.27 μM
|
Cytotoxicity against human MIA PaCa-2 pancreatic cancer cells assessed as viability reduction by MTT assay.
Cytotoxicity against human MIA PaCa-2 pancreatic cancer cells assessed as viability reduction by MTT assay.
|
42810192 |
| HCT-116 | IC50 |
2.05 μM
|
Cytotoxicity against human HCT-116 colon cancer cells assessed as viability reduction by MTT assay.
Cytotoxicity against human HCT-116 colon cancer cells assessed as viability reduction by MTT assay.
|
42810192 |
| HT-29 | IC50 |
2.98 μM
|
Cytotoxicity against human HT-29 colon cancer cells assessed as viability reduction by MTT assay.
Cytotoxicity against human HT-29 colon cancer cells assessed as viability reduction by MTT assay.
|
42810192 |
| A498 | IC50 |
4.32 μM
|
Cytotoxicity against human A498 renal cancer cells assessed as viability reduction by MTT assay.
Cytotoxicity against human A498 renal cancer cells assessed as viability reduction by MTT assay.
|
42810192 |
| CAKI-1 | IC50 |
3.42 μM
|
Cytotoxicity against human CAKI-1 renal cancer cells assessed as viability reduction by MTT assay.
Cytotoxicity against human CAKI-1 renal cancer cells assessed as viability reduction by MTT assay.
|
42810192 |
| MCF7 | IC50 |
4.44 μM
|
Cytotoxicity against human MCF-7 breast cancer cells assessed as viability reduction by MTT assay.
Cytotoxicity against human MCF-7 breast cancer cells assessed as viability reduction by MTT assay.
|
42810192 |
| MDA-MB-231 | IC50 |
7.94 μM
|
Cytotoxicity against human MDA-MB-231 breast cancer cells assessed as viability reduction by MTT assay.
Cytotoxicity against human MDA-MB-231 breast cancer cells assessed as viability reduction by MTT assay.
|
42810192 |
| A549 | IC50 |
7.81 μM
|
Cytotoxicity against human A549 lung cancer cells assessed as viability reduction by MTT assay.
Cytotoxicity against human A549 lung cancer cells assessed as viability reduction by MTT assay.
|
42810192 |
| BEAS-2B | IC50 |
45.3 μM
|
Cytotoxicity against noncancerous human Beas2b cells assessed as viability reduction by MTT assay.
Cytotoxicity against noncancerous human Beas2b cells assessed as viability reduction by MTT assay.
|
42810192 |
In Vitro
Apoptosis inducer 67 (0.27 μM; 72 h) reduces overall tyrosine kinase activity by 0.3-fold in MIA PaCa-2 cells[1].
Apoptosis inducer 67 (72 h) reduces ERK phosphorylation in MIA PaCa-2 cells without altering AKT phosphorylation[1].
Apoptosis inducer 67 (0.27 μM; 72 h) induces caspase-3-mediated apoptosis in MIA PaCa-2 cells through a Bax/Bcl-2-independent pathway, accompanied by elevated cytochrome C and p53[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:human colon HCT-116 and HT-29, lung A549, pancreatic MIA PaCa-2, renal A498 and CAKI-1, breast MDA-MB-231 and MCF-7 cancer cells, and noncancerous Beas2b cells
-
Concentration:0.1-100 μM
-
Incubation Time:48 or 72 h (Table 1); 72 h (Table 2)
-
Result:IC50 values were MIA PaCa-2 0.27 μM (SI = 167.8); HCT-116 2.05 μM; HT-29 2.98 μM; A498 4.32 μM; CAKI-1 3.42 μM; MCF-7 4.44 μM; MDA-MB-231 7.94 μM; A549 7.81 μM; Beas2b 45.3 μM.
-
Cell Line:MIA PaCa-2 pancreatic cancer cells
-
Concentration:0.27 μM (IC50)
-
Incubation Time:72 h
-
Result:Viable cells were 63.9%; early apoptosis was 26.6%; late apoptosis was 9.0%; necrosis was 0.5%; early- and late-stage apoptotic populations increased by approximately 36% compared with control.
Chemical Information
-
CAS No. 3031972-22-9
-
Molecular Weight 368.40
-
Formula C24H17FN2O
-
SMILES
O=C1/C(C(C=C(F)C=C2)=C2N1CC3=CC=CC=C3)=C\C4=CNC5=C4C=CC=C5
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Apoptosis inducer 67 Related Classifications
HY-190534 Related Classifications
Powered by Bioz